Tag: Biotech
ImmunityBio and Microsoft team up to precisely model how key COVID-19 protein leads to infection
An undertaking that involved combining massive amounts of graphics processing power could provide key leverage for researchers looking to develop potential cures and treatments for the novel coronavirus behind the current global pandemic. Immunotherapy startup ImmunityBio is working with Microsoft’s Azure to deliver a combined 24 petaflops of GPU computing…
Read More
Researchers to study if startup’s wrist-worn wearable can detect early COVID-19 respiratory issues
It’s highly unlikely that the current coronavirus crisis will neatly and fully “solved” by any one endeavor or solution, which makes news studies like one involving startup WHOOP’s wrist-worn fitness and health tracking wearable all the more important. The study, conducted by the Central Queensland University Australia (CQUniversity), in partnership…
Read More
FDA introduces a new program to expedite deployment of potential coronavirus treatments
The U.S. Food and Drug Administration (FDA) announced a new program today that’s designed to foster close collaboration between public and private organizations in order to “bring coronavirus treatments to market as fast as possible,” according to U.S. Department of Health & Human Services Secretary Alex Azar in a press…
Read More
Color is launching a high-capacity COVID-19 testing lab and will open-source its design and protocols
Genomics health technology startup Color is doing its part to address the global COVID-19 pandemic, and has detailed the steps it’s taking to support expansion of testing efforts in a new blog post and letter from CEO Othman Laraki on Tuesday. The efforts include development of a high-throughput lab that…
Read More
Cue Health awarded $13 million government contract to develop portable, point-of-care COVID-19 test
Biotech startup Cue Health has secured a $13 million contract from the U.S. Department of Health and Human Service’s Biomedical Advanced Research and Development Authority (BARDA), which will be used to speed the development and testing of a handheld molecular test that can detect the presence of the SARS-CoV-2 novel…
Read More
Leading VCs discuss how COVID-19 has impacted the world of digital health
In December 2019, Extra Crunch spoke to a group of investors leading the charge in health tech to discuss where they saw the most opportunity in the space leading into 2020. At the time, respondents highlighted startups in digital therapeutics, telehealth and mental health that were improving medical practitioner efficiency…
Read More